openPR Logo
Press release

ENovate Biolife reports encouraging results for their Rhinitis Product

10-19-2011 05:13 PM CET | Health & Medicine

Press release from: ENovate Biolife

ENovate Biolife, a specialty healthcare company, announced new data showing how the company’s lead investigational product E-RH-06 will work for the metabolic management of chronic or recurrent, non-infective nasal congestion with-or-without rhinorrhea.
Acute or chronic inflammation of nasal mucous membrane is a hallmark of rhinitis, which may be caused by viruses, bacteria or irritants. The inflammation results in the generation of excessive amounts of mucus, nasal congestion, sneezing and itchiness of nose, throat, eyes, and ears. The key pro-inflammatory cytokines (TNF-, IL-6, IL-8, IL-4, IL-5, IL-13, and GMCSF) play pivotal role in development of the inflammatory milieu in rhinitis.
The present in-vitro study utilized Human nasal epithelial cell line and Human airway epithelium cell line to elucidate the anti-rhinitic potential of E-RH-06 by assessing the modulation in key pro-inflammatory cytokines (IL-6 & IL-8). The E-RH-06 results reflected decline in the levels of key pro-inflammatory markers IL-6 & IL-8 being at par with Loratidine.
E-RH-06 is firstly being developed for metabolic management of Rhinitis (allergic or non allergic), which is among the most worldwide prevalent clinical problem. Many of the available therapies focus on symptomatic relief or have questionable abuse liability, creating need in this market, which ENovate Biolife is working to meet.
“The completion of preclinical studies is a key milestone helping us understand the disease mechanisms and serves as solid foundation for clinical evaluation in patients, said Jayesh Chaudhary, Director of ENovate Biolife. This in-vitro study provides significant additional support for continuing our Phase IIa study to develop E-RH-06.”

About ENovate Biolife
ENovate Biolife is a Specialty Healthcare Company actively involved in Design and Development of Scientifically validated Dietary Supplements and Medical Foods. ENovate is part of a Multinational group with presence in US and Asia, having 2 decades of experience in the Healthcare industry. ENovate is committed to offer Innovative Science based products to support optimal health.

ENOVATE BIOLIFE LLC.
552, Shorebird Circle, Unit # 1101,
Redwood City,
CA 94065 USA
Tel: (650) 855-4832
URL: www.enovatebiolife.com
Email: bizdev@enovatebiolife.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release ENovate Biolife reports encouraging results for their Rhinitis Product here

News-ID: 196918 • Views:

More Releases for Human

I AM HUMAN
Camerata Europæa (CE), inspired by the kaleidoscope of unique current events in the world, presents a cultural program for the year 2022/23 under the motto I AM HUMAN. New perceptions, new morals, new technologies, and ultimately a whole new world, shape modern man. With the progress of science and the evolution of technology, man has comprehended previously unimaginable concepts, marking great and admirable achievements. However, the powerful mechanisms of modern
The Human Whisperer
'The Human Whisperer' Finlay McArthur Published in Austin Macauley Publishers Ltd on 30th of June 2020, both in paperback and eBook version. The Human Whisperer is the second book by Finlay on his quest to give his readers a better understanding of life. This book will help the reader understand that as humans, there is so much more to us than we think. We are connected to the world both physically and
Human Physiology 2019
Human Physiology 2019 Theme: Exploring the Principles of Physiology & Metabolism September 16-17, 2019 | London, United Kingdom Lexis Conferences cordially invites all the members of different nations to attend this annual meet which is scheduled to hold on September 16-17, 2019 at London, United Kingdom based on theme Exploring the Principles of Physiology & Metabolism. A two days scientific meet will gather scientists, students and healthcare industries under one roof to build
Building A Better Human: The Future Of Human Augmentation
Market Scenario: Human augmentation is usually used to denote technologies that enhance human efficiency or capability, that in some way add to the human body. Technological advancements in many areas of IT have directed to a greater variety of implants and other technologies that can be classed as human augmentation.Human augmentation may also be named human 2.0. Within the greater group of human augmentation technologies, some diverse classifications can be made.
Human Microbiome Market
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our
Human Microbiome Market
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our